Literature DB >> 24198480

Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy.

Longjiang Zhang1, Hongwei Chen, Liya Wang, Tian Liu, Julie Yeh, Guangming Lu, Lily Yang, Hui Mao.   

Abstract

Radiation therapy is an effective cancer treatment option in conjunction with chemotherapy and surgery. Emerging individualized internal and systemic radiation treatment promises significant improvement in efficacy and reduction of normal tissue damage; however, it requires cancer cell targeting platforms for efficient delivery of radiation sources. With recent advances in nanoscience and nanotechnology, there is great interest in developing nanomaterials as multifunctional carriers to deliver therapeutic radioisotopes for tumor targeted radiation therapy, to monitor their delivery and tumor response to the treatment. This paper provides an overview on developing nanoparticles for carrying and delivering therapeutic radioisotopes for systemic radiation treatment. Topics discussed in the review include: selecting nanoparticles and radiotherapy isotopes, strategies for targeting nanoparticles to cancers, together with challenges and potential solutions for the in vivo delivery of nanoparticles. Some examples of using nanoparticle platforms for the delivery of therapeutic radioisotopes in preclinical studies of cancer treatment are also presented.

Entities:  

Keywords:  cancer; delivery; nanoparticle; radiation therapy; radioisotope

Year:  2010        PMID: 24198480      PMCID: PMC3781699          DOI: 10.2147/NSA.S7462

Source DB:  PubMed          Journal:  Nanotechnol Sci Appl        ISSN: 1177-8903


  71 in total

1.  Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer.

Authors:  Jing Chen; Hua Wu; Deyan Han; Changsheng Xie
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

2.  Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.

Authors:  Michael R Zalutsky
Journal:  J Nucl Med       Date:  2006-08       Impact factor: 10.057

3.  Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In.

Authors:  Xinrong Liu; Yi Wang; Kayoko Nakamura; Sumi Kawauchi; Ali Akalin; Dengfeng Cheng; Ling Chen; Mary Rusckowski; Donald J Hnatowich
Journal:  J Nucl Med       Date:  2009-03-16       Impact factor: 10.057

Review 4.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

5.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Authors:  Jolanta F Kukowska-Latallo; Kimberly A Candido; Zhengyi Cao; Shraddha S Nigavekar; Istvan J Majoros; Thommey P Thomas; Lajos P Balogh; Mohamed K Khan; James R Baker
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

Review 6.  Targeted therapy of cancer with radiolabeled antibodies.

Authors:  David M Goldenberg
Journal:  J Nucl Med       Date:  2002-05       Impact factor: 10.057

7.  Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

Authors:  Chunfu Zhang; Manfred Jugold; Eva C Woenne; Twan Lammers; Bernd Morgenstern; Margareta M Mueller; Hanswalter Zentgraf; Michael Bock; Michael Eisenhut; Wolfhard Semmler; Fabian Kiessling
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  18F-FDG PET/CT for monitoring the response of lymphoma to radioimmunotherapy.

Authors:  Heather A Jacene; Ross Filice; Wayne Kasecamp; Richard L Wahl
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

9.  Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.

Authors:  F Hartmann; E M Horak; K Garmestani; C Wu; M W Brechbiel; R W Kozak; J Tso; S A Kosteiny; O A Gansow; D L Nelson
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

10.  Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatized surface coatings.

Authors:  Brad A Kairdolf; Michael C Mancini; Andrew M Smith; Shuming Nie
Journal:  Anal Chem       Date:  2008-03-07       Impact factor: 6.986

View more
  8 in total

1.  RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.

Authors:  Hui Li; Piotr G Rychahou; Zheng Cui; Fengmei Pi; B Mark Evers; Dan Shu; Peixuan Guo; Wei Luo
Journal:  Nucleic Acid Ther       Date:  2015-05-27       Impact factor: 5.486

2.  Development of GATE Monte Carlo Code for Simulation and Dosimetry of New I-125 Seeds in Eye Plaque Brachytherapy.

Authors:  Payvand Taherparvar; Zeinab Fardi
Journal:  Nucl Med Mol Imaging       Date:  2021-01-11

3.  A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy.

Authors:  Yang Liu; Jeffrey R Ashton; Everett J Moding; Hsiangkuo Yuan; Janna K Register; Andrew M Fales; Jaeyeon Choi; Melodi J Whitley; Xiaoguang Zhao; Yi Qi; Yan Ma; Ganesan Vaidyanathan; Michael R Zalutsky; David G Kirsch; Cristian T Badea; Tuan Vo-Dinh
Journal:  Theranostics       Date:  2015-05-23       Impact factor: 11.556

4.  Gold nanoparticle-based brachytherapy enhancement in choroidal melanoma using a full Monte Carlo model of the human eye.

Authors:  Somayeh Asadi; Mehdi Vaez-zadeh; S Farhad Masoudi; Faezeh Rahmani; Courtney Knaup; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

5.  Comparison of radiobiological parameters for 90Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro.

Authors:  Yaser H Gholami; Kathy P Willowson; Nicholas J Forwood; Rozelle Harvie; Nicholas Hardcastle; Regina Bromley; HyunJu Ryu; Samuel Yuen; Viive M Howell; Zdenka Kuncic; Dale L Bailey
Journal:  EJNMMI Phys       Date:  2018-09-03

6.  Improving 131I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nanoparticles.

Authors:  Marine Le Goas; Marie Paquet; Aurélie Paquirissamy; Julien Guglielmi; Cathy Compin; Juliette Thariat; Georges Vassaux; Valérie Geertsen; Olivier Humbert; Jean-Philippe Renault; Géraldine Carrot; Thierry Pourcher; Béatrice Cambien
Journal:  Int J Nanomedicine       Date:  2019-09-30

Review 7.  Matrices and Affinity Ligands for Antibody Purification and Corresponding Applications in Radiotherapy.

Authors:  Aiying Xue; Saijun Fan
Journal:  Biomolecules       Date:  2022-06-12

8.  Radio-enhancement effects by radiolabeled nanoparticles.

Authors:  Yaser Hadi Gholami; Richard Maschmeyer; Zdenka Kuncic
Journal:  Sci Rep       Date:  2019-10-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.